Robert Arthur Harrington, Director at CYTOKINETICS INC (CYTK), sold 2,150 shares at $66.80 ($144K) on 2025-12-01, disclosed to the SEC on 2025-12-02.
Scheduled sale ($144k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CYTK | SELL | 2025-03-04 | $38K | — | Filing → |
| CYTK | SELL | 2024-07-08 | $14K | — | Filing → |
| CYTK | SELL | 2024-06-05 | $154K | — | Filing → |